Resultados de la búsqueda

Fernández-Gallego N, Castillo-González R, Moreno-Serna L, García-Cívico AJ, Sánchez-Martínez E, López-Sanz C, Fontes AL, Pimentel LL, Gradillas A, Obeso D, Neuhaus R, Ramírez-Huesca M, Ruiz-Fernández I, Nuñez-Borque E, Carrasco YR, Ibáñez B, Martín P, Blanco C, Barbas C, Barber D, Rodríguez-Alcalá LM, Villaseñor A, Esteban V, Sánchez-Madrid F, Jiménez-Saiz R. Allergic inflammation triggers dyslipidemia via IgG signalling. ALLERGY (2024) 79:2680-2699.
Link to the full text in Repisalud

Rodrigo-Muñoz JM, Naharro-González S, Callejas S, Relaño-Ruperez C, Torroja C, Benguria A, Lorente-Sorolla C, Gil-Martínez M, García de Castro Z, Cañas JA, Valverde-Monge M, Bernaola J, Pinillos-Robles EJ, Betancor D, Fernández-Nieto M, Dopazo A, Sánchez-Cabo F, Sánchez-Pernaute O, Rodríguez-Nieto MJ, Sastre J, Del Pozo V. Single-cell RNA sequencing of human blood eosinophils reveals plasticity and absence of canonical cell subsets. ALLERGY (2024) 80:570-574

Herrero-Alonso M, Marin AV, Fernandez Megino R, Estevez-Benito I, Chacon Arguedas D, Ramiro A, Dominguez M, Moreno I, Gaspar Alonso-Vega ML, Cortegano I, de Andres B, Vinuela-Martin M, Real-Arevalo I, Subiza JL, Gonzalez-Garcia S, Arellano I, Alarcon B, Ortiz Romero PL, Regueiro JR. Toward patient-tailored immunotherapy: targeting the TCR idiotype of clonal Sezary lymphomas. EUR J CANCER (2024) 211:S15-S16

Toribio-Fernandez R, Ceron C, Tristão-Pereira C, Fernandez-Nueda I, Perez-Castillo A, Fernandez-Ferro J, Moro MA, Ibañez B, Fuster V, Cortes-Canteli M. Oral anticoagulants: A plausible new treatment for Alzheimer's disease? Br J Pharmacol (2024) 181:760-776
Link to the full text in Repisalud

Semerano A, Fernández-Ruiz J, Cortes-Canteli M, Moro MA. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. Br J Pharmacol (2024) 181:755-759
Link to the full text in Repisalud

González-Correa C, Moleón J, Miñano S, Robles-Vera I, Toral M, Barranco AM, Martín-Morales N, O'Valle F, Guerra-Hernández E, Sánchez M, Gómez-Guzmán M, Jiménez R, Romero M, Duarte J. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs. Br J Pharmacol (2024) 181:3420-3444
Link to the full text in Repisalud

Erkens R, Duse DA, Brum A, Chadt A, Becher S, Siragusa M, Quast C, Müssig J, Roden M, Cortese-Krott M, Ibáñez B, Lammert E, Fleming I, Jung C, Al-Hasani H, Heusch G, Kelm M. Inhibition of proline-rich tyrosine kinase 2 restores cardioprotection by remote ischaemic preconditioning in type 2 diabetes. Br J Pharmacol (2024) Jul 2 [Epub ahead of print]

Ochoa JP, Lalaguna L, Mirelis JG, Dominguez F, Gonzalez-Lopez E, Salas C, Roustan G, McGurk KA, Zheng SL, Barton PJR, Ware JS, Gómez-Gaviro MV, Lara-Pezzi E, Garcia-Pavia P. Biallelic Loss of Function Variants in Myocardial Zonula Adherens Protein Gene (MYZAP) Cause a Severe Recessive Form of Dilated Cardiomyopathy. Circ Heart Fail (2024) 17:e011226.
Link to the full text in Repisalud

Garcia-Pavia P, Palomares JFR, Sinagra G, Barriales-Villa R, Lakdawala NK, Gottlieb RL, Goldberg RI, Elliott P, Lee P, Li H, Angeli FS, Judge DP, MacRae CA; REALM-DCM Investigators. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy. Circ Heart Fail (2024) 17:e011548.

Villalba-Orero M, López-Olañeta M, Campos-Olmo B, Jimenez-Carretero D, Sánchez L, Sánchez-Cabo F, Ausiello A, Cañas-Álvaro R, Camafeita E, Vázquez J, García-Pavía P, Pascual-Figal D, Lara-Pezzi E. Unraveling Comorbidities Contribution to Cardiac Diastolic Dysfunction and Heart Failure. Circ Heart Fail (2024) 18:e011724